(March 2, 2017, 8:37 AM EST) -- WASHINGTON, D.C. — An Indiana federal judge erred in deeming two patents covering a “breakthrough” treatment for hypogonadism invalid, the patent owners recently told the Federal Circuit U.S. Court of Appeals (Eli Lilly and Company, et al., v. Perrigo Company, et al., Nos. 2016-2555, -2614, Fed. Cir.)....